Targeting aurora kinase a (AURKA) in cancer: molecular docking and dynamic simulations of potential AURKA inhibitors

A Almilaibary - Medical Oncology, 2022 - Springer
The Aurora family of serine/threonine kinases in mammals are key regulators of mitotic
progression and are commonly upregulated in human tumors. Since AURKA's increased …
被引用次数：5 相关文章

Targeting aurora kinase a (AURKA) in cancer: molecular docking and dynamic simulations of potential AURKA inhibitors

A Almilaibary - Medical Oncology, 2022 - search.proquest.com
The Aurora family of serine/threonine kinases in mammals are key regulators of mitotic
progression and are commonly upregulated in human tumors. Since AURKA's increased …

Targeting aurora kinase a (AURKA) in cancer: molecular docking and dynamic simulations of potential AURKA inhibitors

A Almilaibary - Medical oncology (Northwood, London …, 2022 - pubmed.ncbi.nlm.nih.gov
The Aurora family of serine/threonine kinases in mammals are key regulators of mitotic
progression and are commonly upregulated in human tumors. Since AURKA's increased …

Targeting aurora kinase a (AURKA) in cancer: molecular docking and dynamic simulations of potential AURKA inhibitors.

A Almilaibary - Medical Oncology (Northwood, London, England), 2022 - europepmc.org
The Aurora family of serine/threonine kinases in mammals are key regulators of mitotic
progression and are commonly upregulated in human tumors. Since AURKA's increased …